Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noopur S Raje

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Cancer Discovery|August 10, 2013
Targeting BRAF in multiple myelomaElizabeth O'Donnell, Noopur S Raje
Therapeutic Advances in Hematology|February 17, 2017
New monoclonal antibodies on the horizon in multiple myelomaElizabeth K O'Donnell, Noopur S Raje
Hematology. American Society of Hematology. Education Program|December 4, 2016
Sequencing of nontransplant treatments in multiple myeloma patients with active diseaseAndrew J Yee, Noopur S Raje
Future Oncology (London, England)|October 21, 2017
Denosumab for the treatment of bone disease in solid tumors and multiple myelomaAndrew J Yee, Noopur S Raje
Clinical Interventions in Aging|September 15, 2012
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patientsAndrew J Yee, Noopur S Raje
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Myeloma bone disease: pathogenesis and treatmentElizabeth K O'Donnell, Noopur S Raje
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Role of the RANK/RANKL Pathway in Multiple MyelomaNoopur S Raje, Sumita Bhatta, Evangelos Terpos
Current Osteoporosis Reports|September 2, 2017
Myeloma and Bone DiseaseCristina Panaroni, Andrew J Yee, Noopur S Raje
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Advances in supportive care for multiple myelomaNoopur S Raje, Andrew J Yee, G David Roodman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 24, 2026
Outcomes of combined bispecific antibody and radiation therapy in relapsed/refractory hematologic malignanciesHazim S Ababneh, Andrew J Yee, Noopur S Raje, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Cancer Discovery|August 10, 2013
Targeting BRAF in multiple myelomaElizabeth O'Donnell, Noopur S Raje
Therapeutic Advances in Hematology|February 17, 2017
New monoclonal antibodies on the horizon in multiple myelomaElizabeth K O'Donnell, Noopur S Raje
Hematology. American Society of Hematology. Education Program|December 4, 2016
Sequencing of nontransplant treatments in multiple myeloma patients with active diseaseAndrew J Yee, Noopur S Raje
Future Oncology (London, England)|October 21, 2017
Denosumab for the treatment of bone disease in solid tumors and multiple myelomaAndrew J Yee, Noopur S Raje
Clinical Interventions in Aging|September 15, 2012
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patientsAndrew J Yee, Noopur S Raje
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Myeloma bone disease: pathogenesis and treatmentElizabeth K O'Donnell, Noopur S Raje
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Role of the RANK/RANKL Pathway in Multiple MyelomaNoopur S Raje, Sumita Bhatta, Evangelos Terpos
Current Osteoporosis Reports|September 2, 2017
Myeloma and Bone DiseaseCristina Panaroni, Andrew J Yee, Noopur S Raje
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Advances in supportive care for multiple myelomaNoopur S Raje, Andrew J Yee, G David Roodman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 24, 2026
Outcomes of combined bispecific antibody and radiation therapy in relapsed/refractory hematologic malignanciesHazim S Ababneh, Andrew J Yee, Noopur S Raje, et al.
Pageof 7